Acadia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Acadia Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acadia Pharmaceuticals Inc
Rating: 2.095624875
Author: Trendlyne DVM scores

Await Turnaround

about

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare dise...

25.09 -0.51 (-1.99%)

27.43% Gain from 52W Low

1.5M

XNAS Volume

XNAS 20 Jul, 2026 5:30 PM (EDT)

Low Financial Strength

33.3 / 100

Mid Valuation

49.3 / 100

Technically Neutral

51.7 / 100

Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM

1Yr Price target upside is 30%

20 analysts

Acadia Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acadia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare dise...

27.43% Gain from 52W Low

SWOT Analysis

Acadia Pharma Inc Live Price Chart

Acadia Pharma Inc Live Price Chart